The Cooper Companies Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
The Cooper Companies Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for The Cooper Companies were recently set by ten distinguished experts, with an average mark of $110.00. If it reached this goal, it would represent a potential upside of approximately 22.32% from the previous closing price in April, 2024. The high end is $125.00, and the low is $86.25. If you're looking for The Cooper Companies (COO) stock information, you might also want to check out Visioneering Technologies (ASX:VTI).
22.32% Upside
The Cooper Companies Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, The Cooper Companies's Price has decreased by 100.00%, going from $279.27 to $0.00. In the next year, analysts believe that Fair Value will reach $527.25 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$146.82 | Buy/Sell | $174.55 | 15.79% |
| ABBV Stock Forecast | AbbVie | Outperform |
9
|
$167.29 | Buy/Sell | $178.42 | 12.98% |
| NOVN Stock Forecast | Novartis | Hold |
10
|
CHF90.00 | Buy/Sell | CHF105.00 | 19.58% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$25.26 | Buy/Sell | $32.87 | 20.74% |
| ISRG Stock Forecast | Intuitive Surgical | Outperform |
13
|
$373.12 | Buy/Sell | $408.45 | 15.24% |
The Cooper Companies Revenue Forecast for 2023 - 2025 - 2030
In the last three years, The Cooper Companies's Revenue has grown, rising from $2.43B to $3.59B – a growth of 47.81%. In the next year, analysts believe that Revenue will reach $3.94B – an increase of 9.52%. For the next seven years, the forecast is for Revenue to grow by 24.36%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SYK Stock Forecast | Stryker Corp | Outperform |
10
|
$337.15 | Buy/Sell | $353.16 | 8.71% |
| MDT Stock Forecast | Medtronic | Outperform |
11
|
$79.25 | Buy/Sell | $92.47 | 20.50% |
| EL Stock Forecast | EssilorLuxottica Société ano... | Outperform |
12
|
201.60€ | Buy/Sell | 193.26€ | 2.18% |
.jpg)
The Cooper Companies Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, The Cooper Companies's Dividend per Share has decreased from $0.06 to $0.02 – a 66.67% drop. In the next year, analysts believe that Dividend per Share will reach $0.06 – an increase of 200.00%. For the next seven years, experts predict that The Cooper Companies's Dividend per Share will grow at a rate of 200.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ZTS Stock Forecast | Zoetis | Outperform |
18
|
$153.36 | Buy/Sell | $220.47 | 44.11% |
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$88.01 | Buy/Sell | $91.18 | 10.21% |
| IDXX Stock Forecast | IDEXX Laboratories | Outperform |
14
|
$489.24 | Buy/Sell | $583.92 | 22.64% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALC Stock Forecast | Alcon | Outperform |
8
|
CHF71.56 | Buy/Sell | CHF90.64 | 34.66% |
| 7741 Stock Forecast | HOYA | Outperform |
5
|
¥18.31k | Buy/Sell | ¥17.66k | 14.72% |
| RMD Stock Forecast | ResMed Inc | Outperform |
17
|
$183.42 | Buy/Sell | $201.32 | 11.77% |
The Cooper Companies EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, The Cooper Companies's EBITDA has grown by 45.25%, rising from $600.50M to $872.20M. For the next year, analysts predict that EBITDA will reach $1.28B – an increase of 46.85%. Over the next seven years, experts believe that The Cooper Companies's EBITDA will grow at a rate of 64.43%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| WST Stock Forecast | West Pharmaceutical Services | Outperform |
18
|
$368.18 | Buy/Sell | $380.80 | 3.21% |
| MTD Stock Forecast | Mettler-Toledo International | Hold |
13
|
$1.23k | Buy/Sell | $1.12k | -0.24% |
| ZBH Stock Forecast | Zimmer Biomet Holdings | Hold |
15
|
$119.75 | Buy/Sell | $132.52 | 13.57% |
The Cooper Companies EBIT Forecast for 2023 - 2025 - 2030
In the last three years, The Cooper Companies's EBIT has grown, moving from $313.40M to $504.50M – an increase of 60.98%. In the next year, analysts predict that EBIT will jump to $1.11B – up 120.78% from the current level. Looking ahead to seven years, experts forecast that EBIT will grow by 153.41%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| STE Stock Forecast | STERIS | Outperform |
13
|
$201.54 | Buy/Sell | $238.33 | 19.58% |
| HOLX Stock Forecast | Hologic | Outperform |
8
|
$75.71 | Buy/Sell | $81.06 | 10.95% |
| VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.47 | Buy/Sell | $11.73 | 4.62% |
The Cooper Companies EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, The Cooper Companies's EPS has decreased by 100.00%, going from $9.64 to $0.00. In the next year, analysts believe that EPS will reach $18.20 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TFX Stock Forecast | Teleflex Inc | Hold |
13
|
$206.71 | Buy/Sell | $263.46 | 28.20% |
| CHE Stock Forecast | Chemed Corp | Outperform |
18
|
$573.34 | Buy/Sell | $611.33 | 21.48% |
| AFX Stock Forecast | Carl Zeiss Meditec | Hold |
18
|
99.00€ | Buy/Sell | 95.38€ | 6.06% |
.jpg)